Published May 23, 2012 on InjuryBoard On February 7, 2012, all federal lawsuits concerning transvaginal mesh products were consolidated into one court in the Southern District of West Virginia before…
Published June 21, 2012 on LawsuitInformation.org Ethicon, a subsidiary of Johnson & Johnson sent letters to the judges in federal and state court overseeing vaginal mesh lawsuits to notify them…
The US FDA approved Caldera Medical’s latest version of Vertessa Lite mesh in June 2015, even though there is ongoing controversy about the safety of these type of devices. Caldera…
On January 4, 2016, the US Food and Drug Administration (FDA) announced a big change for transvaginal mesh. Previously classified as a Class II medical device, the FDA reclassified transvaginal…
Following a mistrial ruling due to inappropriate witness testimony, the federal court in West Virginia overseeing thousands of transvaginal mesh lawsuits, which are consolidated into six different multidistrict litigation (MDL)…
Five Multi-District Litigation trials regarding transvaginal mesh injuries are based out of the U.S. District Court, Southern District of West Virginia. These five MDLs relating to transvaginal mesh, vaginal slings,…
Transvaginal mesh is used to treat patients with pelvic organ prolapse (POP) and stress urinary incontinence (SUI). As a national law firm representing individuals who believe their injuries (stem) from…
Lawsuits involving transvaginal mesh and other surgical implants used to treat stress urinary incontinence (SUI) or pelvic organ prolapse (POP) have been consolidated into five individual Multi-District Litigation (MDL) cases…
Transvaginal mesh lawsuits have been consolidated into five multi-district litigation (MDL) cases in the U.S. District Court for the Southern District of West Virginia. U.S. District Judge Joseph R. Goodwin…
A new study looking at the long term benefits and disadvantages of using transvaginal mesh. Published in September 2013 by The American College of Obstetricians and Gynecologists, the study is…